Erol K. Bayburt

1.7k citations

17 papers · 964 indexed · h-index 15

Co-authors: Arthur Gomtsyan Connie R. Faltynek Heath A. McDonald Prisca Honoré Kennan C. Marsh James P. Sullivan Michael F. Jarvis Lawrence MacPherson
Topics: Synthesis and Reactivity of Heterocycles (6 papers)Ion Channels and Receptors (6 papers)Pain Mechanisms and Treatments (5 papers)
Cited by: Sensory Systems Cancer Research Complementary and alternative medicine
Journals: Journal of Neuroscience Journal of Medicinal Chemistry Journal of Pharmacology and Experimental Therapeutics
Partner nations: United States United Kingdom Switzerland

In The Last Decade

Erol K. Bayburt

17 papers receiving 930 citations

Peers

Countries citing papers authored by Erol K. Bayburt

Since Specialization

Citations

This map shows the geographic impact of Erol K. Bayburt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erol K. Bayburt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erol K. Bayburt more than expected).

Fields of papers citing papers by Erol K. Bayburt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erol K. Bayburt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erol K. Bayburt. The network helps show where Erol K. Bayburt may publish in the future.

Co-authorship network of co-authors of Erol K. Bayburt

This figure shows the co-authorship network connecting the top 25 collaborators of Erol K. Bayburt. A scholar is included among the top collaborators of Erol K. Bayburt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erol K. Bayburt. Erol K. Bayburt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Chroman and tetrahydroquinoline ureas as potent TRPV1 antagonists 2011 ·Bioorganic & Medicinal Chemistry Letters ·Robert G. Schmidt,Erol K. Bayburt,Steven P. Latshaw,John R. Koenig,Jerome F. Daanen,Heath A. McDonald,Bruce R. Bianchi,Chengmin Zhong,Shailen K. Joshi,Prisca Honoré,Kennan C. Marsh,(unknown),Connie R. Faltynek,Arthur Gomtsyan	35
2	(R)-(5-tert-Butyl-2,3-dihydro-1 H-inden-1-yl)-3-(1 H-indazol-4-yl)-urea (ABT-102) Blocks Polymodal Activation of Transient Receptor Potential Vanilloid 1 Receptors in Vitro and Heat-Evoked Firing of Spinal Dorsal Horn Neurons in Vivo 2008 ·Journal of Pharmacology and Experimental Therapeutics ·Carol S. Surowy,Torben R. Neelands,Bruce R. Bianchi,Steve McGaraughty,Rachid El Kouhen,Ping Han,Katharine L. Chu,Heath A. McDonald,Melissa Vos,Wende Niforatos,Erol K. Bayburt,Arthur Gomtsyan,Chih‐Hung Lee,Prisca Honoré,James P. Sullivan,Michael F. Jarvis,Connie R. Faltynek	38
3	Identification of (R)-1-(5-tert-Butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea (ABT-102) as a Potent TRPV1 Antagonist for Pain Management 2008 ·Journal of Medicinal Chemistry ·Arthur Gomtsyan,Erol K. Bayburt,Robert G. Schmidt,Carol S. Surowy,Prisca Honoré,Kennan C. Marsh,Steven M. Hannick,Heath A. McDonald,Jill M. Wetter,James P. Sullivan,Michael F. Jarvis,Connie R. Faltynek,Chih‐Hung Lee	65
4	α-Methylation at benzylic fragment of N-aryl-N′-benzyl ureas provides TRPV1 antagonists with better pharmacokinetic properties and higher efficacy in inflammatory pain model 2007 ·Bioorganic & Medicinal Chemistry Letters ·Arthur Gomtsyan,Erol K. Bayburt,Ryan G. Keddy,Sean Turner,(unknown),Stanley DiDomenico,Richard J. Perner,John R. Koenig,Irene Drizin,Heath A. McDonald,Carol S. Surowy,Prisca Honoré,Joe Mikusa,Kennan C. Marsh,Jill M. Wetter,Connie R. Faltynek,Chih‐Hung Lee	26
5	TRPV1 Receptors in the CNS Play a Key Role in Broad-Spectrum Analgesia of TRPV1 Antagonists 2006 ·Journal of Neuroscience ·Minghua Cui,Prisca Honoré,Chengmin Zhong,Donna M. Gauvin,Joseph P. Mikusa,Gricelda Hernandez,Prem K.G. Chandran,Arthur Gomtsyan,Brian S. Brown,Erol K. Bayburt,Kennan C. Marsh,Benedetta Bianchi,Heath A. McDonald,Wende Niforatos,Torben R. Neelands,Robert B. Moreland,(unknown),(unknown),James P. Sullivan,Connie R. Faltynek	252
6	Structure–activity studies of a novel series of 5,6-fused heteroaromatic ureas as TRPV1 antagonists 2006 ·Bioorganic & Medicinal Chemistry ·Irene Drizin,Arthur Gomtsyan,Erol K. Bayburt,Robert G. Schmidt,Guo Zhu Zheng,Richard J. Perner,Stanley DiDomenico,John R. Koenig,Sean Turner,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	24
7	Synthesis and biological evaluation of 6,7-disubstituted 4-aminopyrido[2,3-d]pyrimidines as adenosine kinase inhibitors 2005 ·Bioorganic & Medicinal Chemistry Letters ·Richard J. Perner,(unknown),(unknown),(unknown),Stanley DiDomenico,Erol K. Bayburt,Karen M. Alexander,Kathy L. Kohlhaas,Michael F. Jarvis,(unknown),Shripad S. Bhagwat	29
8	Synthesis and structure-activity relationships of 5-heteroatom-substituted pyridopyrimidines as adenosine kinase inhibitors 2003 ·European Journal of Medicinal Chemistry ·Gregory A. Gfesser,Erol K. Bayburt,Marlon Cowart,Stanley DiDomenico,Arthur Gomtsyan,(unknown),Andrew O. Stewart,Michael F. Jarvis,Elizabeth A. Kowaluk,Shripad S. Bhagwat	31
9	5,6,7-Trisubstituted 4-Aminopyrido[2,3-d]pyrimidines as Novel Inhibitors of Adenosine Kinase 2003 ·Journal of Medicinal Chemistry ·Richard J. Perner,(unknown),(unknown),Erol K. Bayburt,(unknown),Karen M. Alexander,Kathy L. Kohlhaas,Carol T. Wismer,Joe Mikusa,Michael F. Jarvis,Elizabeth A. Kowaluk,Shripad S. Bhagwat	21
10	Structure–activity studies of 5-substituted pyridopyrimidines as adenosine kinase inhibitors 2001 ·Bioorganic & Medicinal Chemistry Letters ·Marlon Cowart,(unknown),Gregory A. Gfesser,Erol K. Bayburt,Shripad S. Bhagwat,Andrew O. Stewart,Haixia Yu,Kathy L. Kohlhaas,Steve McGaraughty,Carol T. Wismer,Joseph P. Mikusa,Chang Zhu,Karen M. Alexander,Michael F. Jarvis,Elizabeth A. Kowaluk	24
11	Design of Adenosine Kinase Inhibitors from the NMR-Based Screening of Fragments 2000 ·Journal of Medicinal Chemistry ·Philip J. Hajduk,Arthur Gomtsyan,Stanley DiDomenico,Marlon Cowart,Erol K. Bayburt,Larry R. Solomon,Jean M. Severin,Richard A. Smith,Karl A. Walter,Thomas F. Holzman,Andrew O. Stewart,Steve McGaraughty,Michael F. Jarvis,Elizabeth A. Kowaluk,Stephen W. Fesik	46
12	ChemInform Abstract: trans‐2,6‐, 3,6‐ and 4,6‐Diaza‐5,6,6a,7,8,12b‐hexahydrobenzo[c]phenanthrene‐10,11‐diols as Dopamine Agonists. 1999 ·ChemInform ·Yu Gu,Erol K. Bayburt,(unknown),Chun Wel Lin,Kazumi Shiosaki	1
13	trans-2,6-, 3,6- and 4,6-Diaza-5,6,6a,7,8,12b-hexahydrobenzo[C]phenanthrene-10,11-diols as dopamine agonists 1999 ·Bioorganic & Medicinal Chemistry Letters ·Yu Gu,Erol K. Bayburt,Michael R. Michaelides,Chun Wei Lin,Kazumi Shiosaki	5
14	Discovery of CGS 27023A, a Non-Peptidic, Potent, and Orally Active Stromelysin Inhibitor That Blocks Cartilage Degradation in Rabbits 1997 ·Journal of Medicinal Chemistry ·Lawrence MacPherson,Erol K. Bayburt,Michael Capparelli,Brian J. Carroll,R Goldstein,(unknown),Lijuan Zhu,Shou‐Ih Hu,Richard Melton,(unknown),(unknown),John Doughty,(unknown),V. Blancuzzi,(unknown),Elizabeth O’Byrne,Vishwas Ganu,David T. Parker	288
15	Substituted Hexahydrobenzo[f]thieno[c]quinolines as Dopamine D1-Selective Agonists: Synthesis and Biological Evaluation in Vitro and in Vivo 1997 ·Journal of Medicinal Chemistry ·Michael R. Michaelides,(unknown),Stanley DiDomenico,Erol K. Bayburt,Karen E. Asin,Donald R. Britton,Chun Wel Lin,Kazumi Shiosaki	35
16	Synthesis of 4-alkyl-3,5-dibromo-, 3-bromo-4,5-dialkyl- and 3,4,5-trialkylpyridines via sequential metalation and metal-halogen exchange of 3,5-dibromopyridine 1996 ·Tetrahedron Letters ·Yu Gu,Erol K. Bayburt	22
17	Design and synthesis of an orally active macrocyclic neutral endopeptidase 24.11 inhibitor 1993 ·Journal of Medicinal Chemistry ·Lawrence MacPherson,Erol K. Bayburt,Michael Capparelli,Regine S. Bohacek,Frank H. Clarke,(unknown),Yumi Sakane,Carol Berry,Jane Peppard,Angelo J. Trapani	22

About Erol K. Bayburt

Erol K. Bayburt is a scholar working on Sensory Systems, Complementary and alternative medicine and Organic Chemistry, having authored 17 papers that have together received 964 indexed citations. Recurring topics across this work include Synthesis and Reactivity of Heterocycles (6 papers), Ion Channels and Receptors (6 papers) and Pain Mechanisms and Treatments (5 papers). The work is most often cited by research in Sensory Systems (282 citations), Cancer Research (191 citations) and Complementary and alternative medicine (90 citations). Erol K. Bayburt has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Arthur Gomtsyan, Connie R. Faltynek, Heath A. McDonald, Prisca Honoré, Kennan C. Marsh, James P. Sullivan, Michael F. Jarvis, Lawrence MacPherson, Michael Capparelli and Lijuan Zhu. Their work appears in journals such as Journal of Neuroscience, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact